Assembly Biosciences, Inc.

ASMB ·Healthcare, Drug Manufacturers - General, United States
Financial Statements Income Statement
Annual Quarterly

Income Statement

Line Item FY2010 FY2009 FY2008 FY2007
Revenue
Cost of Revenue
Gross Profit
Gross Margin
Operating Expenses
Research & Development $1.9M $2.9M
SG&A Expense $2.9M $397.2K
Operating Income $-4.8M $-3.3M
Operating Margin
Interest Expense $2.0M $1.1M
Pretax Income
Income Tax Expense
Net Income $-15.3M $-4.5M $-8.8M $-4.6M
Net Margin
EPS (Basic) $-24.67 $-10.02
EPS (Diluted) $-24.67 $-10.02
Shares Outstanding (Basic) 6.7M
Shares Outstanding (Diluted) 6.7M
Dividends Per Share
← Newer Page 3 of 3 Older →